Female patients make up nearly 65% of GLP-1 users nationwide, and around 5.2% of women with obesity are prescribed a GLP-1 medication (compared to 4.2% of men)
Lin C-H, Aljuffali IA, Fang J-Y
GLP-1 also protects insulin-producing beta cells from apoptosis (programmed cell death) and promotes their proliferation (Jellinger 2011
Oxidative stress can result from the presence of persistent organic pollutants, metals, pesticides, toxins, pharmaceuticals, and nanomaterials, as well as changes in temperature or oxygen in water, the examined species, with differences in age, sex, or reproductive cycle of an individual
Where These Numbers Come From The retatrutide + cagrilintide combination has no published clinical trial as of May 2026
As a result of IGF-1 changes, IGFBPs are also altered in T2D [255]